TopNews

Washington, Sept 27 : Though cancer patients and health specialists believe that acupuncture offers relief from radiotherapy-induced nausea, a new study has revealed that it does not.

Washington, Sept 27: According to a new study a new molecular target in blood clot formation has been found which may help to reduce clotting without any excessive bleeding.

unveils a new molecular target for anti-platelet drugs, which may avoid the dangerous side-effects of the current drugs."

The study, led by Shafi Kuchay and Dr. Athar Chishti, was made at the University of Illinois at Chicago College of Medicine.

Washington, Sept 27: A researcher at Tel Aviv University’s Sackler School of Medicine has developed what could be a new weight-loss wonder drug, which not only quells the desire to consume fatty foods, but also has fewer side effects.

Dr. Nir Barak developed the drug in conjunction with the drug company Obecure.

The drug, called HistaleanTM, is based on betahistine, an approved drug used for the treatment of vertigo.

Kabul, Sep 27 : US-led coalition troops backed by warplanes have killed about 170 Taliban militants in two major battles in southern Afghanistan. A US-led coalition soldier has also died in the operation.

Fighting with the insurgents erupted on Tuesday in Helmand, a Taliban stronghold, and continued till Wednesday, a statement from the US-led coalition said.

"The initial estimate by a ground forces commander assessed that more than 104 insurgents were killed thus far in the engagement," it said. The figures could not be verified independently.

Washington, Sept 27 : American researchers have developed a new drug, that when administered along with chemotherapy, shows promise in treating advanced melanoma, delaying the progression of cancer and prolonging the lives of patients.

The new drug, STA-4783, is the first in a new class called oxidative stress inducers.